Follow
GIOVANNI FRANCESCO PELLICANO
GIOVANNI FRANCESCO PELLICANO
Unime
Verified email at unime.it
Title
Cited by
Cited by
Year
The role of the hospital environment in the healthcare-associated infections: a general review of the literature.
A Facciola, GF Pellicano, G Visalli, IA Paolucci, E VENANZI RULLO, ...
European Review for Medical & Pharmacological Sciences 23 (3), 2019
1072019
HIV‐associated psoriasis: epidemiology, pathogenesis, and management
M Ceccarelli, E Venanzi Rullo, M Vaccaro, A Facciolà, F d'Aleo, ...
Dermatologic Therapy 32 (2), e12806, 2019
702019
Physician attitudes and perceptions of complementary and alternative medicine (CAM): a Multicentre Italian study
M Berretta, L Rinaldi, R Taibi, P Tralongo, A Fulvi, V Montesarchio, ...
Frontiers in oncology 10, 594, 2020
692020
Effectiveness of dolutegravir‐based regimens as either first‐line or switch antiretroviral therapy: data from the Icona cohort
A Mondi, A Cozzi‐Lepri, A Tavelli, S Rusconi, F Vichi, ...
African Journal of Reproduction and Gynaecological Endoscopy 22 (1), 2019
662019
Knowledge of sexually transmitted infections and risky behaviours: a survey among high school and university students
G Visalli, B Cosenza, F Mazzù, MP Bertuccio, P Spataro, GF Pellicanò, ...
Journal of preventive medicine and hygiene 60 (2), E84, 2019
652019
Kaposi’s sarcoma in HIV-infected patients in the era of new antiretrovirals
A Facciolà, E Venanzi Rullo, M Ceccarelli, F D'aleo, M Di Rosa, ...
Eur Rev Med Pharmacol Sci 21 (24), 5868-5869, 2017
622017
The new era of vaccines: the" nanovaccinology".
A Facciolà, G Visalli, P Laganà, V La Fauci, R Squeri, GF Pellicanò, ...
European Review for Medical & Pharmacological Sciences 23 (16), 2019
602019
Factors associated with weight gain in people treated with dolutegravir
L Taramasso, P Bonfanti, E Ricci, G Orofino, N Squillace, B Menzaghi, ...
Open Forum Infectious Diseases 7 (6), ofaa195, 2020
562020
Carbon nanotubes and central nervous system: Environmental risks, toxicological aspects and future perspectives
A Facciolà, G Visalli, S La Maestra, M Ceccarelli, F D’Aleo, G Nunnari, ...
Environmental Toxicology and Pharmacology 65, 23-30, 2019
562019
Transmission mode associated with coronavirus disease 2019: a review.
F Vella, P Senia, M Ceccarelli, E Vitale, H Maltezou, R Taibi, A Lleshi, ...
European Review for Medical & Pharmacological Sciences 24 (14), 2020
552020
Malignant melanoma in HIV: Epidemiology, pathogenesis, and management
A Facciolà, E Venanzi Rullo, M Ceccarelli, F D'Andrea, M Coco, C Micali, ...
Dermatologic Therapy 33 (1), e13180, 2020
382020
Investigational drugs in HIV: Pros and cons of entry and fusion inhibitors
E Venanzi Rullo, M Ceccarelli, F Condorelli, A Facciolà, G Visalli, ...
Molecular Medicine Reports 19 (3), 1987-1995, 2019
362019
Head and neck squamous cell carcinoma and its correlation with human papillomavirus in people living with HIV: a systematic review
M Ceccarelli, EV Rullo, A Facciolà, G Madeddu, B Cacopardo, R Taibi, ...
Oncotarget 9 (24), 17171, 2018
352018
High prevalence of undiagnosed anxiety symptoms among HIV-positive individuals on cART: a cross-sectional study
BM Celesia, L Nigro, MR Pinzone, C Coco, R La Rosa, F Bisicchia, ...
Eur Rev Med Pharmacol Sci 17 (15), 2040-2046, 2013
352013
Non-AIDS defining cancers: a comprehensive update on diagnosis and management.
M Ceccarelli, EV Rullo, MA Marino, F d'Aleo, GF Pellicanò, F D'ANDREA, ...
European Review for Medical & Pharmacological Sciences 24 (7), 2020
332020
Efficacy and safety of boosted and unboosted atazanavir‐containing antiretroviral regimens in real life: results from a multicentre cohort study
R Giuntini, C Martinelli, E Ricci, F Vichi, E Gianelli, G Madeddu, C Abeli, ...
HIV medicine 11 (1), 40-45, 2010
322010
The effect of switching from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) on liver enzymes, glucose, and lipid profile
N Squillace, E Ricci, B Menzaghi, GV De Socio, S Passerini, C Martinelli, ...
Drug Design, Development and Therapy, 5515-5520, 2020
312020
Expression of the OAS gene family is highly modulated in subjects affected by juvenile dermatomyositis, resembling an immune response to a dsRNA virus infection
G Musumeci, P Castrogiovanni, I Barbagallo, D Tibullo, C Sanfilippo, ...
International journal of molecular sciences 19 (9), 2786, 2018
262018
New generation biologics for the treatment of psoriasis and psoriatic arthritis. State of the art and considerations about the risk of infection
M Ceccarelli, E Venanzi Rullo, M Berretta, B Cacopardo, GF Pellicanò, ...
Dermatologic Therapy 34 (1), e14660, 2021
242021
Evolution of major non‐HIV‐related comorbidities in HIV‐infected patients in the Italian Cohort of Individuals, Naïve for Antiretrovirals (ICONA) Foundation Study cohort in the …
A d'Arminio Monforte, H Diaz‐Cuervo, A De Luca, F Maggiolo, ...
HIV medicine 20 (2), 99-109, 2019
242019
The system can't perform the operation now. Try again later.
Articles 1–20